{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-059331","form_type":"8-K","ticker":"RSSS","cik":"0001386301","company_name":"Research Solutions, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.192178+00:00","generated_at":"2026-06-02T05:18:15.924992+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Research Solutions Q3 revenue $12.1M (+17% YoY); ARR $16.6M (+82%); adjusted EBITDA record $961K","bullets":["Total revenue $12.1M, up 17% YoY; platform revenue $4.0M (+76% YoY).","ARR grew 82% to $16.6M, with B2B ARR $11.7M and B2C ARR $4.9M.","Net income $76K ($0.00 EPS) vs $237K ($0.01) prior; adjusted EBITDA record $961K vs $559K.","Gross margin improved 630 bps to 45.2%; operating cash flow record over $2M.","Launched two new product offerings: Technology Landscape and Clinical Trial Landscape."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-059331","json":"https://secwatch.observer/filing/0001104659-24-059331.json","markdown":"https://secwatch.observer/filing/0001104659-24-059331.md","text":"https://secwatch.observer/filing/0001104659-24-059331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386301/000110465924059331/0001104659-24-059331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386301/000110465924059331/tm2413961d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T05:18:15.924992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b9f447a6fd86bab2f1df16eefdef15f9fd1c8db1","claim":"Research Solutions, Inc. reported third quarter ended March 31, 2024 results: revenue $12.1 million, net income $76,000, EPS $0.00 per diluted share.","evidence_excerpt":"reported financial results for its fiscal third quarter ended March 31, 2024. Fiscal Third Quarter 2024 Summary (compared to prior-year quarter) · Total revenue of $12.1 million, a 17% increase. · Platform revenue up 76% to $4.0 million. Annual Recurring Revenue (“ARR”) up 82% to $16.6 million, which includes approximately $11.7 million of B2B","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1386301/000110465924059331/0001104659-24-059331-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended March 31, 2024"},{"label":"Revenue","value":"$12.1 million"},{"label":"Net income","value":"$76,000"},{"label":"EPS","value":"$0.00 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}